Home » Health » Hereditary Disease Tests Expanded: 2 New Conditions Added

Hereditary Disease Tests Expanded: 2 New Conditions Added


Expanded Genetic Carrier tests Offer Hope for Hereditary Diseases

In a move hailed as a “huge relief” by families,Quebec is expanding its genetic carrier tests to include additional hereditary diseases. The announcement,made Friday by Municipal Affairs Minister Andrée laforest,aims to provide prospective parents with crucial information for family planning. These genetic carrier tests are designed to identify individuals who carry genes for specific diseases, allowing them to assess the risk of passing these conditions on to their children.

Mothers Share Emotional reactions

The announcement was particularly poignant for parents of children affected by hereditary diseases.Geneviève Gagnon, Audrey Imbault, and Joëlle Boulianne expressed their shared emotion upon hearing the news. Gagnon, mother of Elliot Bouchard who suffered from type II mucolipidosis, described the moment as a profound relief, stating they had almost given up hope.

Hereditary Disease Tests Expanded: 2 New Conditions Added
Elliot Bouchard, the son of Geneviève Gagnon, suffered from type II mucolipidosis. (Sophie Lavoie/The Daily)

Audrey Imbault,whose son Félix Demers had the same disease,emphasized the importance of the announcement for future parents. She noted that advances in research would allow them to plan proactively, something she and others were unable to do.

Pro Tip: Genetic counseling can help individuals and couples understand the implications of carrier testing results and explore available options.

“We are happy to see that there are advances in research for hereditary diseases. It will allow future parents to plan for that, which sadly we could not do on our side.”

– Audrey Imbault, Félix Demers’s mother

Joëlle Boulianne highlighted the broader impact of increased awareness, noting that after the tests became available, nearly all her family members rushed to get tested.

Understanding Carrier Tests

Carrier tests involve genetic analyses performed on cell samples, typically from a mouth swab. Luigi Bouchard, head of the molecular and genetic biology department of the Saguenay-Lac-Saint-Jean CIUSSS, explained the criteria for including diseases in these tests. According to the Centers for Disease Control and Prevention (CDC), carrier testing can help identify if someone carries a gene mutation for a disease.

Did You No? The “founder effect” can lead to higher rates of certain genetic disorders in specific populations due to a limited gene pool.

Bouchard noted that diseases considered for inclusion are frequently enough more prevalent in the region, linked to infantile death, and lack therapeutic options. He also revealed that his team is currently evaluating the addition of 15 new hereditary diseases to the carrier tests.

Luigi Bouchard, head of the Molecular and Genetic Biology Service of the Saguenay-Lac-Saint-Jean.
The head of the Molecular and Genetic Biology Service of the Saguenay-Lac-Saint-Jean, Luigi Bouchard. (Sophie Lavoie/The Daily)

“Before submitting the candidacy of a disease, there is the aspect of research. You have to know its history and its characteristics,it must be evaluated.”

– Luigi Bouchard, head of the molecular and genetic biology department of the Saguenay-Lac-Saint-Jean

The addition of these 15 diseases is expected to be a multi-year process, reflecting the rigorous evaluation required.

Key Considerations for Inclusion in Carrier Tests

Factor Description
Regional Prevalence The disease is more common in the specific geographic area.
Founder Effect A higher incidence due to a limited ancestral gene pool.
Severity Association with infantile death or significant morbidity.
Therapeutic Options Limited or no effective treatments available.

The Broader Context of Genetic Testing

Genetic testing has evolved significantly over the past few decades. Initially focused on diagnosing existing conditions, it has expanded to include predictive and carrier testing. This evolution is driven by advances in genomic technology and a growing understanding of the genetic basis of disease. According to a 2023 report by Future Market Insights, the global genetic testing market is projected to reach $37.7 billion by 2033, driven by increasing awareness and accessibility.

Carrier testing plays a crucial role in reproductive health. By identifying carriers, couples can make informed decisions about family planning, including options such as in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) to select embryos without the genetic mutation.

Frequently Asked Questions About Genetic Carrier Testing

What are genetic carrier tests?
Genetic carrier tests are analyses performed on cell samples to identify individuals who carry a gene mutation for a particular hereditary disease. While carriers usually don’t exhibit symptoms, they can pass the mutation to their children.
Why are genetic carrier tests important?
These tests allow prospective parents to understand their risk of having a child with a genetic disorder. This knowledge enables them to make informed decisions about family planning and consider options like preimplantation genetic diagnosis (PGD) or prenatal testing.
What factors determine which diseases are included in carrier tests?
Several factors are considered, including the disease’s frequency in a specific population, the presence of a ‘founder effect’ (where a mutation is more common due to a small ancestral group), the severity of the disease (particularly if it leads to infantile death), and the availability of therapeutic options.
How are genetic carrier tests performed?
Carrier tests are typically conducted using cell samples, frequently enough collected from a simple mouth swab.The DNA is then analyzed to identify specific gene mutations associated with targeted hereditary diseases.
What is the significance of expanding genetic carrier testing?
Expanding the panel of diseases included in carrier tests provides more comprehensive information to individuals and couples. It empowers them to make proactive choices regarding their reproductive health and potentially prevent the transmission of severe genetic conditions to future generations.
What are the next steps in expanding genetic carrier testing?
The process involves extensive research to understand the history and characteristics of each disease being considered. This evaluation determines whether the disease meets the criteria for inclusion in carrier tests, a process that can take several years.

The information provided in this article is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

What impact do you think expanded genetic testing will have on future generations? How would you use this information in your own family planning?

Share your thoughts and experiences in the comments below!

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.